Uroxatral and Aneurysm - a phase IV clinical study of FDA data

Summary:

Aneurysm is reported as a side effect among people who take Uroxatral (alfuzosin hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Warfarin Sodium, and have Diabetes.

The phase IV clinical study analyzes which people have Aneurysm when taking Uroxatral. It is created by eHealthMe based on reports of 3,182 people who have side effects when taking Uroxatral from the FDA, and is updated regularly.

What is Uroxatral?

Uroxatral has active ingredients of alfuzosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 3,461 Uroxatral users. Check the latest studies of Uroxatral.

What is Aneurysm?

Aneurysm (enlargement of an artery caused by a weakening of the artery wall) is found to be associated with 566 drugs and 702 conditions by eHealthMe. Check the latest studies of Aneurysm.

On Jul, 13, 2026

3,182 people reported to have side effects when taking Uroxatral.
Among them, 12 people (0.38%) have Aneurysm.

Among these 12 people:

How long have people been on Uroxatral when they have Aneurysm? *

What is the gender of people who have Aneurysm when taking Uroxatral? *

female: 0.0 %
male: 100 %

What is the age of people who have Aneurysm when taking Uroxatral? *

What are other drugs people take besides Uroxatral? *

Ammonium Lactate: 12 people, 100.00%
Warfarin Sodium: 12 people, 100.00%
Ambien: 10 people, 83.33%
Oxycontin: 10 people, 83.33%
Lantus: 10 people, 83.33%
Cymbalta: 10 people, 83.33%
Diprolene: 5 people, 41.67%
Novolog: 5 people, 41.67%
Hydrocodone Bitartrate And Acetaminophen: 5 people, 41.67%
Fentanyl-50: 5 people, 41.67%

What are other side effects people have besides Aneurysm? *

Skin - Clammy: 12 people, 100.00%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 100.00%
High Blood Pressure: 12 people, 100.00%
Haemorrhagic Stroke (stroke caused by the rupture of a blood vessel in the brain): 12 people, 100.00%
Fall: 12 people, 100.00%
Breathing - Slowed Or Stopped: 12 people, 100.00%
Feeling Abnormal: 10 people, 83.33%
Insomnia (sleeplessness): 9 people, 75.00%
Bleeding Disorders: 8 people, 66.67%
Brain Death: 7 people, 58.33%

What are the existing conditions these people have? *

Pain: 12 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 12 people, 100.00%
Micturition Disorder (disease of passing urine): 12 people, 100.00%
Insomnia (sleeplessness): 12 people, 100.00%
Diabetes: 12 people, 100.00%
Pain In Extremity: 5 people, 41.67%
Feeling Of Relaxation: 3 people, 25.00%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 8.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Uroxatral and have Aneurysm?

- Check whether Aneurysm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uroxatral:

Uroxatral (3,461 reports)

Aneurysm treatments and more:

Aneurysm (6,532 reports)

Browse all side effects of Uroxatral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aneurysm:

Aneurysm (566 drugs)

Browse all the conditions that are associated with Aneurysm:

Aneurysm (702 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alfuzosin hydrochloride (the active ingredients of Uroxatral) and Uroxatral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.